Platelet biomarkers in Alzheimer’s disease

Por Talib, Leda L, Joaquim, Helena PG, Forlenza, Orestes V
Publicado em 2012

Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment

Por Radanovic, Márcia, Stella, Florindo, Silva, Lis Gomes, Talib, Leda L., Forlenza, Orestes V.
Publicado no Dement Neuropsychol (2017)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia

Por Forlenza, Orestes V., Radanovic, Marcia, Talib, Leda L., Aprahamian, Ivan, Diniz, Breno S., Zetterberg, Henrik, Gattaz, Wagner F.
Publicado no Alzheimers Dement (Amst) (2015)

Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression

Por Diniz, Breno S., Teixeira, Antonio L., Machado-Vieira, Rodrigo, Talib, Leda L., Radanovic, Marcia, Gattaz, Wagner F., Forlenza, Orestes V.
Publicado em 2014

Oxidative stress in early stage Bipolar Disorder and the association with response to lithium

Por de Sousa, Rafael T., Zarate, Carlos A., Zanetti, Marcus V., Costa, Alana C., Talib, Leda L., Gattaz, Wagner F., Machado-Vieira, Rodrigo
Publicado em 2013

Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer’s disease?

Por Rabelo, Ana GB, Teixeira, Camila VL, Magalhães, Thamires NC, Carletti-Cassani, Ana Flávia MK, Amato Filho, Augusto CS, Joaquim, Helena PG, Talib, Leda L, Forlenza, Orestes, Ribeiro, Patrícia AO, Secolin, Rodrigo, Lopes-Cendes, Iscia, Cendes, Fernando, Balthazar, Marcio LF
Publicado no Neuroradiol J (2017)